These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 16101277
41. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1. Williams RS, Green R, Glover JN. Nat Struct Biol; 2001 Oct; 8(10):838-42. PubMed ID: 11573086 [Abstract] [Full Text] [Related]
43. Conserved BRCT regions of TopBP1 and of the tumor suppressor BRCA1 bind strand breaks and termini of DNA. Yamane K, Tsuruo T. Oncogene; 1999 Sep 16; 18(37):5194-203. PubMed ID: 10498869 [Abstract] [Full Text] [Related]
47. Structure of a second BRCT domain identified in the nijmegen breakage syndrome protein Nbs1 and its function in an MDC1-dependent localization of Nbs1 to DNA damage sites. Xu C, Wu L, Cui G, Botuyan MV, Chen J, Mer G. J Mol Biol; 2008 Aug 29; 381(2):361-72. PubMed ID: 18582474 [Abstract] [Full Text] [Related]
48. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure. Joo WS, Jeffrey PD, Cantor SB, Finnin MS, Livingston DM, Pavletich NP. Genes Dev; 2002 Mar 01; 16(5):583-93. PubMed ID: 11877378 [Abstract] [Full Text] [Related]
49. Hereditary breast cancer and the BRCA1-associated FANCJ/BACH1/BRIP1. Cantor SB, Guillemette S. Future Oncol; 2011 Feb 01; 7(2):253-61. PubMed ID: 21345144 [Abstract] [Full Text] [Related]
50. BRCA1 accelerates CtIP-mediated DNA-end resection. Cruz-García A, López-Saavedra A, Huertas P. Cell Rep; 2014 Oct 23; 9(2):451-9. PubMed ID: 25310973 [Abstract] [Full Text] [Related]
51. Structural evidence for direct interactions between the BRCT domains of human BRCA1 and a phospho-peptide from human ACC1. Shen Y, Tong L. Biochemistry; 2008 May 27; 47(21):5767-73. PubMed ID: 18452305 [Abstract] [Full Text] [Related]
53. Phosphopeptide interactions of the Nbs1 N-terminal FHA-BRCT1/2 domains. Kim K, Kirby TW, Perera L, London RE. Sci Rep; 2021 Apr 27; 11(1):9046. PubMed ID: 33907233 [Abstract] [Full Text] [Related]
54. Breast cancer risk and the BRCA1 interacting protein CTIP. Gorringe KL, Choong DY, Lindeman GJ, Visvader JE, Campbell IG. Breast Cancer Res Treat; 2008 Nov 27; 112(2):351-2. PubMed ID: 18095152 [Abstract] [Full Text] [Related]
56. The interaction between CtIP and BRCA1 is not essential for resection-mediated DNA repair or tumor suppression. Reczek CR, Szabolcs M, Stark JM, Ludwig T, Baer R. J Cell Biol; 2013 May 27; 201(5):693-707. PubMed ID: 23712259 [Abstract] [Full Text] [Related]
57. Three-Dimensional Architecture of the Human BRCA1-A Histone Deubiquitinase Core Complex. Kyrieleis OJP, McIntosh PB, Webb SR, Calder LJ, Lloyd J, Patel NA, Martin SR, Robinson CV, Rosenthal PB, Smerdon SJ. Cell Rep; 2016 Dec 20; 17(12):3099-3106. PubMed ID: 28009280 [Abstract] [Full Text] [Related]
58. Thermal unfolding of human BRCA1 BRCT-domain variants. Nikolopoulos G, Pyrpassopoulos S, Thanassoulas A, Klimentzou P, Zikos C, Vlassi M, Vorgias CE, Yannoukakos D, Nounesis G. Biochim Biophys Acta; 2007 Jun 20; 1774(6):772-80. PubMed ID: 17493881 [Abstract] [Full Text] [Related]
59. Impact of RING and BRCT domain mutations on BRCA1 protein stability, localization and recruitment to DNA damage. Nelson AC, Holt JT. Radiat Res; 2010 Jul 20; 174(1):1-13. PubMed ID: 20681793 [Abstract] [Full Text] [Related]